Ultimate magazine theme for WordPress.

The Next Generation in Cannabinoid Delivery Systems Has Arrived in Remedy-Specific Offerings


Nano Mist Aerosol Technology Combined with Targeted Formulations

CENTENNIAL, Colo. – March 9, 2021 /Canna Newswire/ – Monarch Life Sciences LLC, (Dba Monarch Meds) is pleased to announce the launch of a new e-commerce consumer direct initiative, MonarchMeds.com, for persons looking for premium quality CBD and other cannabinoid-based products with an advanced delivery system using Nano Mist Aerosol Technology. The site will initially launch five full-spectrum, cannabinoid derived product categories – Nano Mist Atomizer (Inhalers), Nano Mist Sublinguals, Topical Relief & Refresh Sprays, Aqua Vita™ Beverage Infusions and Pet Health Drops.

Utilizing proprietary cannabinoid-based formulations (e.g., CBD, CBG, CBN, CBC), in combination with vitamins, herbs, botanicals and micro-nutrients with specialized aerosol delivery systems, Monarch has created the next generation of premium cannabinoid-based products for general use available direct to consumers online via a robust e-commerce platform. Directly addressing remedy-specific offerings (i.e., BALANCE, ENERGY, RELAX, SLEEP, FOCUS, IMMUNITY), Monarch offers an array of full-spectrum cannabinoids, flavors, daily/PM formulas, and various oral delivery systems for convenient discrete adult-use while also providing formulations for topicals, beverage infusion and pet drops.

Monarch is owned and operated by James Matuszewski and all formulations, manufacturing and fulfillment are managed exclusively by Colorado based R2 Innovations, Inc. The collaboration between Monarch and R2 culminates from years of cannabinoid research and product development.

“After several years of developing proprietary processes and with a focus on innovative aerosol delivery systems, R2 is proud to be associated with Monarch’s e-commerce product launch, which highlights and delivers our aerosol product lines direct to consumers.” said R2’s Chief Executive Officer, Robert Senter. “Now that we are seeing positive movement, and progress towards legislative reform in the legal cannabinoid industry, Monarch’s product offerings are uniquely positioned to offer premium quality cannabinoid-based products through new technology nano mist aerosol advancements in delivery and effectiveness for regular daily affordable use.”

Monarch is capitalizing on key partnerships to offer the most advanced aerosol delivery systems, featuring the most effective entourage of cannabinoids. Monarch also features aerosol products which use patented Purzorb®, micelle technology, a process that produces tiny droplets (micelles) that are then formed into highly absorbable aggregate structures, delivering true, water-soluble, full-spectrum cannabinoids.

Mr. Matuszewski states, “This new aerosol technology is a game changer when compared to other antiquated delivery systems like clumsy, oil-dropper tinctures or low-dose gummies. The ability to offer a more effective product at a lower cost per milligram provides Monarch with the advantage to deliver a premium product direct to consumer at more affordable prices. The higher active bioavailability and better uptake of cannabinoids (CBD and others) provides our customers with the results they expect, quicker and more conveniently.”

In addition to offering this new nano mist technology and innovative aerosol delivery system, Monarch is focused on the overall quality to value of the products to consumers.

James Matuszewski, leading Monarch’s consumer direct online initiative stated, “In most arenas, CBD has just become too expensive for many consumers to afford on a regular basis, not to mention advanced cannabinoids like CBG, CBN and CBC, which we are learning, provide targeted, remedy specific results. We want our customers to use the product freely so they can realize the full benefits of using our products daily for an array of needs or ailments.” James continues, “There is a lot of misinformation out there and an equal amount of sub-par consumer products. We want to educate and provide consumers with real results that meet their expectations as well as provide a good value.”

See Monarch’s CBD FAQs designed to help educate customers.

Monarch Life Sciences, LLC launched the website under the URL MonarchMeds.com debuting their launch with over a dozen product offerings across five key categories. Monarch ships anywhere in the US and all orders of $40 or more ship for free. Monarch also offers a 20% military discount to active or retired service members and their families. Visit Monarch online or email for more information at info@MonarchMeds.com

About Monarch Life Sciences
Monarch Life Sciences, LLC (“MLS”) was established in 2019 as a Colorado Limited Liability Company. MLS provides consumer direct initiatives for proprietary cannabinoid (“CBD”) products, formulations and advanced aerosol technologies along with key niche CBD offerings. Monarch’s products are formulated, manufactured, and distributed directly from their facility located in Centennial, Colorado.

About R2 Innovations
R2 Innovations, Inc. was established in 1998, a privately owned, Colorado Corporation. R2 has established partnerships with industry leaders in the fields of micelle technology and in the drying and micronizing of microparticles and nanoparticles into dry powder aerosols for the purpose of inhalation therapies, targeting the treatment of respiratory diseases, including asthma, emphysema and COPD. In addition to dry powder formulations targeting pulmonary and respiratory disorders; US patent pending processes, research and studies are underway to convert cannabinoid derived formulations into pharmaceutical grade, formulations using a pressurized, metered dose inhaler (pMDI) and dry powder inhaler (DPI) technologies directed at treating stress, post-traumatic stress disorders (PTSD), anti-inflammation, pain relief and insomnia. R2 provides proprietary formulations, manufactures and fulfills products direct to their clients from its Centennial, Colorado laboratory and fulfillment facility. For more: R2Innovations.com

# CNW #

Media Contact:
James Matuszewski
Monarch Life Sciences, LLC
Direct: 720.788.9719

Source link

Leave A Reply

Your email address will not be published.